KDM2B and carcinoma: KDM2B can reduce the proliferation of carcinoma cells by inhibiting the expression of oncogenes that play important roles in the self-renewal, differentiation, and apoptosis of stem cells (Hong et al., 2016; Goyama and Kitamura, 2017).